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The Decline in Stroke Mortality
Exploration of Future Trends in 7 Western European Countries
Anton E. Kunst, PhD; Masoud Amiri, PhD; Fanny Janssen, PhD
Background and Purpose—This article aims to make projections of future trends in stroke mortality in the Year 2030
based on recent trends in stroke mortality in 7 Western European countries.
Methods—Mortality data were obtained from national cause of death registries. Annual rates of decline in stroke mortality
of 1980 to 2005 were determined for men and women in the United Kingdom, France, the Netherlands, and 4 Nordic
countries on the basis of regression analysis. Estimated rates of decline were extrapolated until 2030. Cause-elimination
life tables were used to determine the effect of stroke in 2030 in terms of potential gain in life expectancy. The absolute
numbers of stroke deaths in 2030 were estimated using national population projections of Eurostat.
Results—In all countries, stroke mortality rates declined incessantly until 2005 among both men and women. If these trends
were to continue, age-adjusted mortality rates would decline by approximately half between 2005 and 2030 with larger
declines in France (approximately two thirds) and smaller declines in the Netherlands, Denmark, and Sweden
(approximately one fourth). Similar rates of decline would be observed in terms of potential gain in life expectancy.
Because of population aging, the absolute number of stroke deaths would decline slowly in the United Kingdom and
France and stabilize or even increase in other countries.
Conclusions—In the near future, stroke may lose much of its effects on life expectancy but remain a frequent cause of
death among elderly populations. The prevention of stroke-related disability instead of mortality may become
increasingly more important. (Stroke. 2011;42:2126-2130.)
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Stroke mortality has strongly declined during the 20th cen-tury. Studies from Western Europe1,2 and Northern Amer-
ica3 consistently showed that mortality from stroke declined
until the most recent years of observation. International reviews
showed that this mortality decline is paralleled by declines in
both incidence and case-fatality rates.4 Whereas declining inci-
dence rates are likely to reflect improvements in lifestyles and
environmental exposures in different phases of life, declining
case-fatality rates also reflect ongoing progress in secondary
prevention and treatment of stroke.
The strong declines in the past raise important questions about
the future of stroke mortality. A possible continuation of these
declines may or may not imply that the effect of stroke on life
expectancy would become marginal. Furthermore, the rapid
aging of European populations in the next decades may or may
not compensate for this mortality decline. If it were, the absolute
number of elderly people dying from stroke would increase
rather than decrease in the next decades.
To our knowledge, only a few international studies have
presented projections of future trends in stroke mortality.5 In
addition, some of these projections were based on stroke
mortality trends in the 1980s or early 1990s.6 Taking into
account more recent trends can, however, change future perspec-
tives. Moreover, to create a stable empirical basis for projections
of future trends, it is important to consider stroke mortality
trends over a long span of years.7 Similarly, the empirical basis
for future projections could be expanded by also considering
trends in countries with similar levels of socioeconomic
development.
The aim of this article is to present projections of future trends
in stroke mortality in 7 western European countries until 2030 on
the basis of a careful assessment of past trends in these countries.
Materials and Methods
We obtained data for Denmark, Finland, mainland France, the Nether-
lands, Norway, Sweden, and England and Wales. We selected these
countries because they are heterogeneous enough yet have a comparable
level of wealth and socioeconomic structure, and their long-term
mortality and population data come from data sources that are known to
be of good quality.8,9
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For each country, we obtained data on the number of deaths from stroke
(International Classification of Diseases [ICD] codes 430 to 434 and 436 to
438 for ICD, 8th Revision and ICD, 9th Revision, and I60 to I69 for ICD,
10th Revision) by sex and 5-year age groups for the years 1980 to 2005. In
a previous study, national contact persons extracted detailed mortality data
files with prespecified formats from national cause of death registries.10 In
more recent analyses, additional data for years after 2000 were obtained
from Eurostat (http://epp.eurostat.ec.europa.eu) or national sources.11 Cor-
responding numbers of population at risk were supplied by national
contact persons, or derived from Eurostat, on the basis of data from
population censuses or population registers. Because the study period
included different revisions of the World Health Organization ICD, we
adjusted for effects of coding changes using a regression-based method
that is reported elsewhere.12
To describe trends in stroke mortality between 1980 and 2005,
sex-specific age-standardized mortality rates were calculated using
direct standardization. As the standard population, we took the total
EU25 (the European Union comprising 25 member states) popula-
tion by 5-year age groups in 2005 as the standard population
(http://epp.eurostat.ec.europa.eu). In addition, we estimated sex- and
country-specific annual mortality changes (percent) over the period
1980 to 2005 by means of log-linear regression analysis. The
dependent variable was the number of deaths with the midyear
population numbers as the offset variable. The regression model
included 5-year age groups (from 0 to 80 years) as a categorical
variable and single calendar year as a continuous variable. Annual
mortality changes (percent) were calculated as:
100*expb1,
in which b is the regression coefficient to the calendar year variable.
To project age-specific mortality rates until 2030, we assumed that
the mortality trends from 1980 to 2005 would continue for the next
25 years. We therefore applied the estimates of the annual rate of
change in mortality in the period 1980 to 2005 to the national
age-specific mortality rates in 2005. This projection was made for
each sex and county separately. The projection formula was:
nMxt0tnMxt0  ncx*1t,
where nMx is mortality rate in the age interval x, xn; t0 is the
baseline year 2005; t is the length of the projection period, with
20061 and 203025 years; and c* is the annual rate of mortality
change observed over the period 1980 to 2005.
In general, past mortality declines were larger in younger age groups.
To take this age effect into account, the factor c* was estimated for the
age groups 40 to 59, 60 to 79, and 80 years separately.
The absolute number of stroke deaths was projected by applying
the projected age-specific mortality rates to the projected age-
specific numbers of men and women residing in the different
countries up to 2030. The latter numbers were obtained from
Eurostat taking the baseline population projection. For Norway, data
were obtained from Statistics Norway, taking the medium national
growth variant (http://statbank.ssb.no/statistikkbanken).
We expressed the impact of stroke mortality on life expectancy in
2005 and 2030 by means of the potential gain in life expectancy
measure. This measure measures the extent to which life expectancy
were to increase in case of the hypothetical elimination of stroke. For
2005, we prepared cause-elimination life tables using all-cause
mortality rates and stroke mortality rates observed for 2005. For
2030, we used our own projections of stroke mortality, whereas we
also projected all-cause mortality rates for 2030 using the same
methodology as used for stroke mortality.
For Denmark, stroke mortality data were available until 2001
instead of 2005. Therefore, Year 2001 was used as the end year for
the analysis of past trends in stroke mortality and the baseline year
for future projections of stroke mortality. All-cause mortality rates
for Denmark for 2002 to 2005 were, however, available from the
Human Mortality Database (www.mortality.org).
Results
Figure 1 shows changes in stroke mortality rates in 7 western
European countries according to year of death from 1980 to
2005. In all 7 European countries, stroke mortality rates
declined among both men and women. In the United King-
dom, Norway, and Finland, stroke mortality rates declined by
almost 3% per year. Stronger declines were observed in
France (4% per year). Declines were smallest in Denmark
and Sweden (approximately 1% to 1.5% per year) and the
Netherlands (approximately 2%). The declines persisted until
2005. Although each country shows irregularities in the pace
of decline, there is no consistent evidence for a deceleration
of the mortality decline in recent years.
The Table presents the projected age-standardized mortal-
ity rates for men and women in the 7 countries in 2030. In all
countries, age-adjusted mortality rates would have substan-
tially declined in 2030 compared with 2005 if past trends
were to continue. Age-adjusted mortality rates would decline
by approximately half between 2005 and 2030. Larger
declines would occur in France with the rate ratio of 0.33 for
men indicating a two thirds decline. Smaller declines, of
approximately one fourth, would occur in the Netherlands,
Denmark, and Sweden. In each country, mortality declines
are projected to larger among men than among women.
In terms of potential gain in life expectancy, the importance of
stroke mortality would also decline to an important extent. When
averaged across all countries, the potential gain in life expec-
tancy for men declines from 0.87 years in 2005 to 0.48 years in
2030. For women, the potential gain in life expectancy declines
from 1.35 to 0.81 years. Thus, in 2030, the hypothetical
elimination of stroke mortality would increase life expectancy at
birth by approximately 0.5 years for men and 0.8 years for
women. This effect is about equally large in most countries in
2030. The potential gain in life expectancy approaches 1 year
only for Swedish and Danish women. Estimates less than 0.50
years are projected for France.
Figure 2 shows the projected absolute number of stroke
deaths from 2005 until 2030. This number is projected to
decline in the United Kingdom and in France in the first 15 or
20 years. In both countries, this decline would, however,
stagnate and even reverse after 2020, when the postwar baby
boom cohort will enter old age (70 years). In the Nether-
lands, Sweden, and Denmark, increases in the absolute
number of stroke deaths are projected to occur over the entire
period, but especially after 2020. Relative stable numbers of
deaths are projected for Norway and Finland.
Discussion
We observed a strong decline in stroke mortality in the past
decades, both among men and women, in each of the 7 countries
studied. If these trends were to continue in the future, stroke
mortality rates in 2030 would be substantially lower than they
were in 2005. Similarly, strong declines would be observed in
the effect of stroke on life expectancy. In 2030, this effect would
be less than 1 year in nearly all female populations and
approximately 0.5 year in most male populations.
Despite this decline in stroke mortality risk, the absolute
number of deaths from stroke will not substantially decline
and even increase at the shorter and longer term. This
increase is due to the aging of the national populations,
especially after Year 2020, when the baby boom generations
will reach old age. However, although its effect on life
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expectancy would decline, stroke would remain a common
cause of death in western Europe’s aging populations.
A potential data problem relates to the coding of underly-
ing causes of death in national published statistics. Problems
related to changes in subsequent revisions of the ICD have
been evaluated by our team and taken into account where
necessary.10,12 Changes over time in certification practices by
physicians are another area of concern, although they are
unlikely to explain the observed decline in stroke mortality.13
Moreover, similar rates of mortality decline have been
observed in epidemiological studies with standardized ascer-
tainment of stroke cases within registration areas.14
Our results for 7 western European countries cannot be
generalized to other regions of the world. Recent trends in
stroke mortality in eastern European countries strongly dif-
fered from those in the West,15 implying that the East might
differ also with regard to future trends in stroke mortality.
Similarly, trends in stroke incidence and case-fatality in
low-income countries were found to notably differ from the
trends in high-income countries.4 On the other hand, in the
United States, stroke mortality has declined over recent
decades with approximately 0.3% to 2.9% per year,16 sug-
gesting similar rates of decline as in western Europe.11–13
Acknowledged demographers, Wilmoth7 and Oepen and
Vaupel,17 argue that future trends in mortality can best depart
from extrapolations of past trends in mortality as observed over
a longer period. We therefore based our projections on the
declines in stroke mortality as observed in the 7 European
countries over a 25-year period. The precise rate of mortality
decline varied between countries as it did between subsequent
decades. This variability warns us that it is difficult to accurately
predict future mortality trends for specific countries during
specific decades. We therefore concentrated on longer-term
projections and similarities in these projections across the 7
countries, which essentially reflect the substantial and persistent
decline in stroke mortality found in all countries in the past 25
years.
The strong decline in stroke mortality in past decades is likely
to be attributable to declines in both case-fatality rates and in
incidence rates. There is consistent evidence from a large
number of epidemiological studies for a steady improvement in
survival rates of patients with stroke. For example, an analysis of
the complete data of the Monitoring Trends and Determinants in
Cardiovascular Disease (MONICA) study concluded that the
stroke mortality decline was attributable for approximately two
thirds to declining case-fatality rates.18 However, because this
study was limited to individuals 35 to 64 years of age, it is
uncertain whether this high estimate is representative for the
older ages in which most stroke deaths occur.
Figure 1. Trend between 1980 and 2005
stroke mortality rates (rates per 100,000
person-years, standardized using the Euro-
pean Union comprising 25 member states
[EU25] population by 5 years as the stan-
dard population). Men and women in 7
European countries.
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With regard to stroke incidence, the evidence is less
consistent, because several studies reported no decrease,19
whereas others did report a decline in incidence rates.20
However, a systematic review of all available evidence
concluded that stroke incidence substantially declined be-
tween the 1970s and the 2000s in high-income countries.21
Moreover, variations in stroke mortality trends between
high-income and low-income countries, and between eastern
and western Europe, are paralleled by similar variations in
trends in the incidence of stroke.4 Further support comes from
the finding that key risk factors for stroke incidence (eg,
smoking, hypertension, and raised serum cholesterol) could
explain at least half of the secular decline in stroke mortality
in some countries.22,23
Future reductions in stroke mortality are likely to be
contingent on declines in both incidence rates. Further de-
Table. Age-Standardized Stroke Mortality Rates and Potential Gain in Life Expectancy (PGLE) Observed in 2005 and Projected for
2030: Men and Women in 7 European Countries
Sex Index Year*
Country
Denmark United Kingdom Finland France Netherlands Norway Sweden
Men
Mortality rate† 2005 102.76 105.12 97.54 59.59 76.16 85.05 85.38
Per 100 000 2030 76.00 51.42 50.51 20.35 50.10 47.47 65.16
2030/2005 0.74 0.49 0.52 0.34 0.66 0.56 0.76
PGLE, y 2005 0.87 1.10 0.98 0.70 0.69 0.84 0.88
2030 0.63 0.51 0.48 0.23 0.43 0.45 0.65
2030/2005 0.72 0.46 0.49 0.32 0.63 0.53 0.74
Women
Mortality rate† 2005 90.21 107.97 79.84 47.30 70.69 72.26 72.85
Per 100 000 2030 70.12 57.71 44.12 17.74 51.03 41.14 58.94
2030/2005 0.78 0.53 0.55 0.37 0.72 0.57 0.81
PGLE, y 2005 1.27 1.69 1.56 1.10 1.16 1.35 1.30
2030 0.97 0.85 0.83 0.41 0.82 0.74 1.04
2030/2005 0.76 0.50 0.53 0.37 0.71 0.55 0.80
PGLE indicates potential gain in life expectancy; EU25, the European Union comprising 25 member states.
*2030/2005value for 2030 as ratio to value for 2005.
†Rates per 100 000 person-years standardized using the EU25 population by 5 y as standard population.
Figure 2. Projected trends between 2005 and 2030 in the absolute number of stroke deaths (men and women combined) in 7 Euro-
pean countries.
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clines may follow reductions in the prevalence of risk factors
such as smoking, hypertension, and cholesterol. New vigor-
ous tobacco control policies in western Europe since the
1990s are likely to decrease tobacco exposure rates of
generations that will reach old age in the mid-21st century.24
Moreover, improvement in environmental and socioeconomic
determinants such as the rising educational levels of genera-
tions born in the 20th century may contribute to continued
declines in stroke incidence in the 21st century.25 Further
evidence to expect such a continued decline comes from a
cohort analysis that we performed of the same mortality data
and from which we concluded that the mortality declines
persisted until the youngest generations, possibly due to
improved environmental conditions in early life.11
Conclusions
If the rate of decline in stroke mortality in the past 25 years were
to continue for the next 25 years, stroke would lose much of its
effects on life expectancy, because it would only modestly affect
the life expectancy of men and women in western Europe in
2030. A continued decline in stroke mortality rates would,
however, not be paralleled by a similar decline in the number of
people dying from stroke. Due to aging of the population, the
absolute number of stroke deaths would remain at approximately
the same level. Moreover, the average age of death of patients
with stroke will unavoidably increase. Thus, the absolute num-
ber of elderly patients in need of intensive or terminal treatment
is unlikely to diminish in the next decades.
To the extent that declines in mortality are achieved by
improved survival, instead of decreased incidence, the future
number of patients with stroke would increase at a larger rate
than the number of stroke deaths.18 This would imply that the
future burden of stroke will gradually shift from a (more or less
constant) mortality burden toward a (rising) morbidity burden.
To respond to this shift, more emphasis must be given not only
to enhance preventive strategies, especially for the elderly
people. In addition, improved rehabilitation methods are needed
to reduce disability and comorbidity among elderly patients with
stroke.
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